Cytokinetics to Hold Annual Meeting of Stockholders
May 10, 2018 16:00 ET
|
Cytokinetics, Incorporated
SOUTH SAN FRANCISCO, Calif., May 10, 2018 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq:CYTK) today announced that its Annual Meeting of Stockholders will be held on Wednesday, May 16, 2018...
Cytokinetics and the ALS Association Renew Partnership to Advance the Fight Against ALS
May 01, 2018 07:30 ET
|
Cytokinetics, Incorporated
SOUTH SAN FRANCISCO, Calif. and WASHINGTON, May 01, 2018 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq:CYTK) and The ALS Association today announced the continuation of their partnership in...
Cytokinetics, Inc. Reports First Quarter 2018 Financial Results
April 26, 2018 16:00 ET
|
Cytokinetics, Incorporated
Completed Enrollment in Phase 2 Study of Reldesemtiv in Patients with SMA;Data Expected in Q2 2018 Preparing to Initiate Second Phase 3 Clinical Trial of Omecamtiv Mecarbil SOUTH SAN FRANCISCO,...
Cytokinetics Announces Presentation of Data From Phase 2 Clinical Study of Reldesemtiv in Patients With Spinal Muscular Atrophy at the 2018 Annual Cure SMA Conference
April 24, 2018 07:30 ET
|
Cytokinetics, Incorporated
SOUTH SAN FRANCISCO, Calif., April 24, 2018 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq:CYTK) today announced that data from the Phase 2 clinical study of reldesemtiv in patients with...
Cytokinetics to Announce First Quarter Results on April 26, 2018
April 12, 2018 16:00 ET
|
Cytokinetics, Incorporated
SOUTH SAN FRANCISCO, Calif., April 12, 2018 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq:CYTK) today announced that it is scheduled to report first quarter results on April 26, 2018 at...
Cytokinetics to Present at March Investor Conferences
March 05, 2018 16:00 ET
|
Cytokinetics, Incorporated
SOUTH SAN FRANCISCO, Calif., March 05, 2018 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq:CYTK) announced today that Robert I. Blum, President and Chief Executive Officer, is scheduled to...
Cytokinetics Joins Global Initiative to Recognize International Rare Disease Day
February 28, 2018 07:30 ET
|
Cytokinetics, Incorporated
SOUTH SAN FRANCISCO, Calif., Feb. 28, 2018 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq:CYTK) today announced that it is joining the global initiative to raise awareness of Rare Disease...
Cytokinetics, Inc. Reports Fourth Quarter 2017 Financial Results
February 15, 2018 16:00 ET
|
Cytokinetics, Incorporated
Company Provides 2018 Financial Guidance and Expected Milestones; Reduced Operating Expenses vs. 2017; Over Two Years of Cash Based on Current Burn Rate CK-2127107 Advancing in Four Clinical Trials...
Cytokinetics to Present at the RBC Capital Markets Global Healthcare Conference
February 14, 2018 16:00 ET
|
Cytokinetics, Incorporated
SOUTH SAN FRANCISCO, Calif., Feb. 14, 2018 (GLOBE NEWSWIRE) -- Cytokinetics, Inc. (Nasdaq:CYTK) today announced that Robert I. Blum, President and Chief Executive Officer, is scheduled to present a...
Cytokinetics Names Robert Califf, M.D., to Board of Directors
February 12, 2018 07:30 ET
|
Cytokinetics, Incorporated
SOUTH SAN FRANCISCO, Calif., Feb. 12, 2018 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq:CYTK) today announced that Robert Califf, M.D., has been appointed to the company’s Board of...